| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |